Neurotrophic factors in cerebrospinal fluid and serum of patients with Rett syndrome

Journal of Child Neurology

Volumn 13, Issue 9, 1998, Pages 429-433

  Vanhala, Raija ^a,d   Korhonen, Laura ^b   Mikelsaar, Mait ^c   Lindholm, Dan ^b   Riikonen, Raili ^d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR;

ADOLESCENT; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RETT SYNDROME; SERUM;

EID: 0031714735     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389801300903     Document Type: Article

References (38)

1. Rett A: Über ein Cerebral-atrophisches Syndrom bei Hyperammonämie. Vienna, Brüder Hollinek, 1966, pp 1-68.
2. Hagberg BA, Aicardi J, Dias K, Ramos O: A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: Report of 35 cases. Ann Neurol 1983;14:471-479.
3. Diagnostic Criteria Work Group: Diagnostic criteria for Rett syndrome. Ann Neurol 1988;23:425-428.
4. Hagberg B, Anvret M, Percy A, Wahlstöm J: Conclusion aspects on origin - future approach, in Hagberg B (ed): Rett Syndrome -Clinical and Biological Aspects. London, Mac Keith Press, 1993, pp 111-116.
5. Hagberg B: Rett syndrome: Clinical peculiarities and biological mysteries. Acta Paediatr 1995;84:971-976.
6. Ebendal T: Function and evolution in the NGF family and its receptors. J Neurosci Res 1992;32:461-470.
7. Yuen EC, Howe CL, Yiwen L, et al: Nerve growth factor and the neurotrophic factor hypothesis. Brain Dev 1996;18:362-368.
8. Kasaian MT, Neet KE: Nerve growth factor in human amniotic and cerebrospinal fluid. Biofactors 1989;2:99-104.
9. Patterson SL, Grady MS, Bothwell M: Nerve growth factor and a fibroblast growth factor-like neurotrophic activity in cerebrospinal fluid of brain injured human patients. Brain Res 1993;605:43-49.
10. Laudiero LB, Aloe L, Levi-Montalcini R, et al: Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid. Neurosci Lett 1992;147:9-12.
11. Suzaki I, Hara T, Maegaki Y, et al: Nerve growth factor levels in cerebrospinal fluid from patients with neurologic disorders. J Child Neurol 1997;12:205-207.
12. Lorigados L, Söderström S, Ebendal T: Two-site enzyme immunoassay for beta NGF applied to human patient sera. J Neurosci Res 1992;32:329-339.
13. Murase K, Nabeshima T, Robitaille Y, et al: NGF level is not decreased in the serum, brain-spinal fluid, hippocampus, or parietal cortex of individuals with Alzheimer's disease. Biochem Biophys Res Comm 1993;193:198-203.
14. Haddad J, Vilge V, Juif JG, et al: Beta-nerve growth factor levels in newborn cord sera. Pediatr Res 1994;35:367-369.
15. Dicou E, Masson C, Jabbour W, Nerriere V: Increased frequency of NGF in sera of rheumatoid arthritis and systemic lupus erythematosus patients. Neuroreport 1993;5:321-324.
16. Jockers-Scherübl MC, Zouboulis CC, Boegner F, Hellweg R: Is nerve growth factor a serum marker for neurological and psychiatric complications in Behçet's disease? Lancet 1996;347:1308.
17. Lappalainen R, Lindholm D, Riikonen R: Low levels of nerve growth factor in cerebrospinal fluid of children with Rett syndrome. J Child Neurol 1996;11:296-300.
18. Alderson RF, Alterman AL, Barde YA, Lindsay RM: Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture. Neuron 1990;5:297-306.
19. Radka SF, Holst PA, Fritsche M, Altar CA: Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Res 1996;709:122-301.
20. Barde YA: Trophic factors and neuronal survival. Neuron 1989;2: 1525-1534.
21. Tuszynski MH, Gage FH: Neurotrophic factors and diseases of the nervous system. Ann Neurol 1994;35:9-12.
22. Naidu S: Rett syndrome: A disorder affecting early brain growth. Ann Neurol 1997;42:3-10.
23. Lappalainen R, Riikonen R: High levels of cerebrospinal fluid glutamate in Rett syndrome. Pediatr Neurol 1996;15:213-216.
24. Lindholm D, Dechant G, Heisenberg C-P, Thoenen H: Brain-derived neurotrophic factor is a survival factor for cultured rat cerebellar granule neurons and protects them against glutamate-induced neurotoxicity. Eur J Neurosci 1993;5:1455-1464.
25. Frim DM, Short MP, Rosenberg WS, et al: Local protective effects of nerve growth factor-secreting fibroblasts against excitotoxic lesions in the rat striatum. J Neurosurg 1993;78:267-273.
26. Hanefeld F, Hagberg B, Percy A: Molecular and neurobiology aspects of Rett syndrome. Neuropediatrics 1995;26:60-61.
27. Armstrong D: The neuropathology of Rett syndrome - Overview 1994. Neuropediatrics 1995;26:100-104.
28. Cohen-Cory S, Dreyfus CF, Black IB: NGF and excitatory neurotransmitters regulate survival and morphogenesis of cultured cerebellar Purkinje cells. J Neurosci 1991;11:462-471.
29. Nawa H, Carnahan J, Gall C: BDNF protein measured by a novel enzyme immunoassay in normal brain and after seizure; partial disagreement with mRNA levels. Eur J Neurosci 1995;7:1527-1535.
30. Nielsen JB, Friberg L, Lou H, et al: Immature pattern of brain activity in Rett syndrome. Arch Neurol 1990;47:982-986.
31. Uvebrant P, Bjure J, Sixt R, et al: Regional cerebral blood flow: SPECT as a tool for localization of brain dysfunction, in Hagberg B (ed): Rett Syndrome - Clinical and Biological Aspects. London, Mac Keith Press, 1993, pp 80-85.
32. Lappalainen R, Liewendahl K, Sainio K, et al: Brain perfusion SPECT and EEG findings in Rett syndrome. Acta Neurol Scand 1997;95:44-50.
33. Wenk GL, O'Leary M, Nemeroff CB, et al: Neurochemical alterations in Rett syndrome. Dev Brain Res 1993;74:67-72.
34. Kitt CA, Troncoso JC, Price DL, et al: Pathological changes in substantia nigra and basal forebrain cholinergic neurons in Rett syndrome. Ann Neurol 1990;28:416-417.
35. Wenk GL: Rett syndrome: Evidence for normal dopaminergic function. Neuropediatrics 1996;27:256-259.
36. Buj-Bello A, Buchman VL, Horton A, et al: GDNF is an age-specific survival factor for sensory and autonomic neurons. Neuron 1995;15:821-828.
37. Kozbauer PT, Lampe PA, Heurckeroth RO, et al: Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature 1996;384:467-470.
38. Klein RD, Sherman D, Ho W, et al: A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor. Nature 1997;387:717-721.